Ototoxicity

Chloroquine-related ototoxicity is considered to be rare. ❋ Unknown (2003)

This process that damages the ear is called ototoxicity, using the antibiotic neomycin. ❋ Unknown (2010)

At these higher doses gentamicin is non-selective and extremely toxic to humans, with irreversible hearing loss (ototoxicity) being the main negative consequence. ❋ Unknown (2009)

"Our data favor the use of chemotherapy regimens that contain 20 mg/m2 cisplatin per day to limit ototoxicity." ❋ Unknown (2009)

These include: head injuries like skull fracture, whiplash injury and closed head injury metabolic disorders like hyperlipidemia, vitamin B12 deficiency and thyroid disorder ototoxicity to medications like aspirin presbycusis or hearing loss associated with age earwax impaction hypertonia or muscle tension circulatory problems like hypertension, atherosclerosis and malformation of capillaries ❋ Unknown (2008)

The aim of the study was to compare ototoxicity, tolerability, and efficacy of ACT with that of quinine and atovaquone / proguanil in the treatment of uncomplicated falciparum malaria. ❋ Unknown (2008)

However, irreversible ototoxicity associated with artemether / lumefantrine (AL) has been reported recently and suggested to be a serious limitation in the use of ACT. ❋ Unknown (2008)

Most of the written description details the inventors’ testing ofloxacin on guinea pigs and their findings that ototoxicity did not result from the use of their compound. ❋ Peter Zura (2007)